Composition
- Active ingredients
- LAMIVUDINE 150MG; NEVIRAPINE 200MG; ZIDOVUDINE 300MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA205626.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamivudine, Nevirapine and Zidovudine
- Active substance
- lamivudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Micro Labs
- Status
- Discontinued
- FDA approval
- 13 Aug 2018
- Application
- NDA205626-001